Related Experiment Video
Updated: May 31, 2026

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
[Acute myocardial infarction: diagnosis and treatment]
1Medizinische Klinik II der Universität zu Lübeck. peter.radke@uk-sh.de
Insights
ST-elevation myocardial infarction (STEMI) management has improved due to advances in percutaneous coronary intervention and medications. Optimal treatment requires understanding guidelines and patient factors for better outcomes in this cardiac emergency.
Area of Science:
- Cardiology
- Emergency Medicine
Context:
- Acute ST-elevation myocardial infarction (STEMI) is a life-threatening cardiac emergency.
- Prognosis for STEMI patients has significantly improved over recent decades.
Purpose:
- To highlight advances in STEMI treatment, including interventional techniques and medical therapy.
- To emphasize the importance of timely intervention and appropriate medication selection.
Summary:
- Direct percutaneous recanalization of the infarct-related artery within two hours of first medical contact is the gold standard for STEMI treatment.
- Optimal medical therapy involves a comprehensive understanding of antithrombotic and antithrombin medications, current guidelines, and individual patient characteristics.
Impact:
- Improved survival rates and patient outcomes for STEMI.
- Highlights logistical challenges in emergency care delivery and the need for specialized medical knowledge.
Abstract:
Acute ST-elevation myocardial infarction (STEMI) represents a cardiac emergency with a high early mortality. Over the last decades, prognosis of patients with STEMI has dramatically improved. This has primarily been a result of advances in coronary interventional techniques as well as medical therapy. Direct percutaneous recanalization of the infarct-related artery represents the gold standard in treating STEMI, specifically when performed within two hours after first medical contact. These timelines imply logistical challenges for ambulance and hospital services. Furthermore, the broad variety of antithrombotic (acetylsalicylic acid, P2Y12 and GPIIb/IIIa receptor antagonists) and antithrombin medication (heparins, direct thrombin inhibitors) requires a sound understanding of the current evidence, guidelines and the individual patient characteristics to offer optimal medical therapy to the individual patient.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management

